Miles D. White is Chairman and Chief Executive Officer of Abbott, a global healthcare company with a leading portfolio of products and technologies in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.
Mr. White, who joined Abbott in 1984, became Chairman and CEO in 1999. In addition to being Chairman of the Abbott Board of Directors, Mr. White currently serves on the boards of Caterpillar Inc., and McDonald’s Corporation. He is a member of the board of the US-China Business Council, the Business Council, and the Business Roundtable. He is Chairman of The Culver Educational Foundation, a board trustee of Northwestern University, and a member of the Global Advisory Board at the Kellogg School of Management. He serves on the board of the Lyric Opera of Chicago, and is a fellow of the American Academy of Arts and Sciences. Mr. White was formerly Chairman of the Federal Reserve Bank of Chicago.
Mr. White earned both a bachelor's degree in mechanical engineering and a master's degree in business administration from Stanford University.
Thomas Freyman is Executive Vice President, Finance and Administration. He was appointed to his current role in June 2015. Prior to assuming his current role, he served as Executive Vice President, Finance and Chief Financial Officer.
Mr. Freyman joined Abbott in 1979, and has served in a number of financial planning and analysis positions. He also served as Division Controller, Corporate Materials Management, Vice President and Treasurer, and Vice President and Controller, Hospital Products Division.
Prior to joining Abbott, Mr. Freyman was a certified public accountant with Ernst & Whinney, Chicago.
Mr. Freyman serves as a director of Tenneco. He is also a member of the Economic Club of Chicago, and the American Institute of Certified Public Accountants.
He earned a bachelor's degree in accounting from the University of Illinois and a master's degree in management from Northwestern University.
Hubert L. Allen is Executive Vice President, General Counsel and Secretary. He was appointed to his current role in January 2013. Previously, he served as Divisional Vice President and Associate General Counsel, Established Pharmaceuticals.
Mr. Allen joined Abbott in 2006 as Senior Counsel, supporting the Pharmaceutical Products Division. He has held various positions within the legal department, including Divisional Vice President and Associate General Counsel, Pharmaceutical Products Group; Section Head, Nutrition Legal Operations; and Division Counsel, supporting the Pharmaceutical Products Division.
Prior to joining Abbott, Mr. Allen was Assistant General Counsel for McKesson Corporation.
He graduated with a bachelor's degree from the College of Social Studies at Wesleyan University in Middletown, Connecticut; a master’s degree in Politics from Princeton University in Princeton, New Jersey, and a juris doctorate from Yale Law School in New Haven, Connecticut.
Brian Blaser is Executive Vice President, Diagnostics Products, where he leads Abbott's diagnostics, molecular and point-of-care businesses. He was appointed to his current position in June 2012.
Previously, Mr. Blaser served as Senior Vice President, Diagnostics; Vice President, Diagnostics Operations; Divisional Vice President, Global Operations; and Divisional Vice President, Reagent Manufacturing, all in Abbott Diagnostics.
Prior to joining Abbott, Mr. Blaser held several positions of increasing responsibility in engineering, finance and operations at Johnson & Johnson, Eastman Kodak and General Motors.
He earned a bachelor's degree in mechanical engineering technology from the University of Dayton and a master's degree in business administration from Rochester Institute of Technology.
John Capek, Ph.D., is Executive Vice President, Ventures. Dr. Capek was appointed to his current position in June 2015. In this role, he leads Abbott’s venture investment organization as well as new ventures, including Abbott Electrophysiology. Previously, he had served as Executive Vice President, Medical Devices, and Senior Vice President, Abbott Vascular, heading up Abbott's global vascular business.
Before joining Abbott, Dr. Capek served in various management roles at Guidant Corporation, including president, Guidant Vascular Intervention and vice president and general manager of Bioabsorbable Vascular Solutions. He also served as vice president and general manager of Guidant Germany and vice president, marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Dr. Capek was manager of New Product Technology at Eli Lilly & Company.
He has a bachelor's degree in biomedical engineering, a master's degree in biomedical engineering, a master's degree in electrical engineering, a Ph.D. in biomedical engineering and a master's degree in business administration from Rensselaer Polytechnic Institute.
Robert Ford is Executive Vice President, Medical Devices. He was appointed to his current position in June 2015. Previously, Mr. Ford served as Senior Vice President, Diabetes Care.
Mr. Ford joined Abbott in 1996 as a Diagnostics Business Unit Manager for Abbott Brazil. He has held various positions of increasing responsibility for Abbott Diagnostics, Abbott Nutrition International and Abbott Diabetes Care, including Vice President, Diabetes Care, Commercial Operations.
Prior to joining Abbott, Mr. Ford held a marketing position with Becton Dickinson Brazil where he worked in the consumer products division. He is a member of the California Life Sciences Association Board.
He earned a bachelor’s degree in communications from Boston College and a master’s degree in business administration from UC Berkeley, Haas School of Business.
Steve Fussell is Executive Vice President, Human Resources. He was promoted to this role in February 2013.
Mr. Fussell joined Abbott in 1996, as Divisional Vice President, Compensation and Benefits. He was promoted to Vice President, Compensation and Development in 1999, and to Senior Vice President, Human Resources in 2005.
Prior to Abbott, he held human resources leadership positions at Nestlé and Shell.
Mr. Fussell is Chairman of the Board and President of the Clara Abbott Foundation and a board member of the Abbott Fund. He is an author and speaker on a wide variety of subjects and has served as a guest lecturer at Cornell, Northwestern and other universities. In 2010, he was named to the HR Honor Roll by Human Resources Executive magazine.
He earned a Bachelor of Science degree from Louisiana State University in Baton Rouge.
Heather Mason is Executive Vice President, Nutritional Products. She was appointed to her current role in May 2015. Previously, she served as Executive Vice President, Global Commercial Operations, Abbott Nutrition.
Ms. Mason joined Abbott in 1990. She held a number of positions in Abbott's U.S. pharmaceutical business, including oversight of Abbott's specialty pharmaceuticals, its diabetes/metabolics and oncology franchises, and managed health care. Ms. Mason also served as Vice President, International Marketing, and Vice President, Latin American Operations, in Abbott's international pharmaceutical business. Immediately prior to assuming her role in Abbott’s Nutrition business in 2014, Ms. Mason served as Senior Vice President, Abbott Diabetes Care.
Prior to joining Abbott, Ms. Mason worked for Quaker Oats and FMC Corporation. She is an advisory board member of the Healthcare Businesswomen’s Association.
She earned a bachelor's degree in engineering from the University of Michigan and a master's degree in business administration from the University of Chicago.
Michael Warmuth is Executive Vice President, Established Pharmaceuticals, focusing on expanding the global market for Abbott’s portfolio of branded generic pharmaceuticals. He was appointed to his current role in November 2012.
Most recently, Mr. Warmuth served as Senior Vice President, Established Pharmaceuticals, which previously operated as part of Abbott’s global pharmaceutical business. Mr. Warmuth joined Abbott in 1986 as part of Abbott's manufacturing professional development program. He served in a variety of management roles including Senior Vice President, Diagnostics, heading Abbott’s global core laboratory Diagnostics business; Vice President and General Manager, Hematology, in Abbott's Diagnostics business; Vice President, Global Engineering Services; Divisional Vice President of Pharmaceutical Operations; and Divisional Vice President of Corporate Quality Operations.
He earned a bachelor's degree in business administration from the University of Wisconsin-Whitewater and a master's degree in business administration from Northwestern University.
Roger Bird is Abbott's Senior Vice President, U.S. Nutrition. He was appointed to this role in February 2015.
Prior to assuming his current position, Roger served as Divisional Vice President, General Manager for our Nutrition business in China and Hong Kong.
Roger came to Abbott in 1983 from the Dial Soap Company, where he worked as a sales representative. He joined Abbott as Trade Sales Manager in our Nutrition organization, and has served in this business throughout his Abbott career, contributing to our company's success in both the U.S. and Asia.
While leading Abbott's nutrition business in China, he oversaw the successful launch of Similac Eleva and Similac Qinti, two infant formula products that significantly strengthened Abbott's presence in this important market.
Throughout his career, Roger has taken real pride in contributing to the Abbott Nutrition mission of providing high-quality products that help improve the lives of people of all ages, all around the world.
In addition to his responsibilities with Abbott. Roger serves on the Board of the Grocery Manufacturers Association.
Roger earned his bachelor’s degree in Business Management from Weber State University in Ogden, Utah.
Jaime Contreras is Senior Vice President, Core Laboratory Diagnostics, Commercial Operations. He was appointed to his current role in September 2013. Previously, he served as Vice President, Diagnostics, Global Commercial Operations.
Mr. Contreras joined Abbott in 1992, and has held various management positions in Abbott's Diagnostics Division, including Vice President for Europe, Africa and the Middle East; and General Manager of Commercial Operations in Spain, Portugal and Mexico.
Prior to joining Abbott, Mr. Contreras was area director for Bayer in Mexico.
Mr. Contreras serves on the board of directors of the European Diagnostic Manufacturers Association (EDMA) and on the Board of Directors of the Clara Abbott Foundation.
He earned a bachelor's degree in industrial design from the Universidad Autonoma Metropolitana and a master's degree in business administration with specialty in Financial Engineering from the Universidad del Valle de Mexico.
Thomas Frinzi is Senior Vice President of Abbott’s vision business, which includes a broad ophthalmology portfolio across the areas of cataracts, refractive surgery (LASIK) and eye health products. He was appointed to his position in January 2016.
Prior to joining Abbott, Mr. Frinzi held a number of leadership positions in ophthalmology and medical device companies. Most recently, he served as President and CEO of WaveTec Vision, a developer of surgical systems for eye surgery. He also held senior positions in commercial operations, business development, and sales and marketing at Bausch & Lomb Surgical, Refractec and Johnson & Johnson. In recognition of his leadership, expertise and vision in the field, Mr. Frinzi was awarded the 2015 Ophthalmology Innovation Award by the Ophthalmology Innovation Summit.
He earned a bachelor's degree in political science from the University of Tampa.
Andrew Lane is Senior Vice President, Emerging Markets for Abbott’s Established Pharmaceuticals business since June 2015.
Andrew joined Abbott in 2014 as Divisional Vice President, Asia Pacific, for Established Pharmaceuticals. Prior to Abbott, he was Vice President of Asia Pacific at Takeda Pharmaceuticals. During his 20-year career in emerging markets, Andrew held country and regional positions at Nycomed, Invida, DKSH, Novartis and Sandoz, gaining experience both in the proprietary and branded generics business.
In his current role, Andrew sets the strategic vision for his organization and innovates to increase access to high-quality, affordable medicines for consumers, contributing to Abbott’s mission of helping people live their best possible lives.
He studied at University of Technology, Auckland, New Zealand receiving qualifications in Business management and Finance.
Elaine Leavenworth is Senior Vice President, Chief Marketing and External Affairs Officer. She was appointed to this role in December 2014.
Previously, she had served as Abbott’s Vice President, Government Affairs.
Ms. Leavenworth joined Abbott in 1991 and held various management positions of increasing responsibility in Abbott's Nutrition, International, and Health Systems divisions. She was elected a corporate officer in July of 1999.
Prior to joining Abbott, Ms. Leavenworth was a principal with the consulting firm Louden & Company, where her work focused on marketing and strategy assignments for health care providers, suppliers, investors and associations. While at Louden & Company, she published numerous articles and several books, including The Hospital Group Purchasing Outlook, Home Care Joint Venturing, The Older Adult Market and Home Care - HMO/PPO Perspectives. Ms. Leavenworth also held marketing positions at G.D. Searle & Co. and American Hospital Supply Corporation.
Ms. Leavenworth serves on the Board of Directors of the U.S. Chamber of Commerce, the Board of Trustees of the Goodman Theater, the Board of Advisors of the Duke Global Health Institute, and the Women’s Advisory Board of the Girl Scout Council of the Nation’s Capital. She is a member of the Economic Club of Chicago, The Chicago Network (where she served previously on the board of directors), and the Women’s Forum of Washington, D.C.
She is the President of the Abbott Fund, Abbott’s philanthropic foundation, and she also served on the board of the Clara Abbott Foundation from 2005 to 2014.
She earned a bachelor's degree in health policy from Duke University and a master's degree in business administration from Northwestern University.
Corlis Murray is Senior Vice President, Quality Assurance, Regulatory and Engineering Services. She was appointed to her current position in February 2012. Previously, she served as Vice President, Global Engineering Services.
Ms. Murray joined Abbott in 1989. Since then, she has held a number of management positions in quality, operations and engineering in Abbott’s Diagnostics and Nutrition businesses. In Abbott Nutrition, she served as Divisional Vice President, Quality Assurance; Divisional Vice President, Manufacturing; and Divisional Vice President, Operations Services.
Prior to joining Abbott, Ms. Murray worked at Recognition Equipment and Xerox Corporation. She is a board member of The Clara Abbott Foundation.
She earned a bachelor’s degree in mechanical engineering from Southern University in Baton Rouge, Louisiana.
Deepak Nath, Ph.D. is Senior Vice President, Abbott Vascular. He was appointed to this role in April 2015.
Previously, Deepak served as Vice President, Vascular, Commercial. He joined Abbott in 2007, and held several leadership positions including Vice President, Abbott Molecular and Divisional Vice President & General Manager, Ibis Biosciences. In Abbott Vascular he served as Divisional Vice President, Strategic Marketing; Divisional Vice President & General Manager, Nordics and Eastern European Direct Operations; and, Divisional Vice President, Central and Eastern Europe, Middle East & Africa.
Before joining Abbott, he held leadership roles at Amgen and worked as consultant at McKinsey & Company. He began his career as a scientist in the computational physics group at the Lawrence Livermore National Laboratory.
Deepak earned his bachelor’s and master’s degrees in Mechanical Engineering, as well as a Ph.D. in Theoretical Mechanics (Mechanical Engineering), from the University of California, Berkeley.
Jean-Yves Pavée is Senior Vice President, Developed Markets for Abbott’s Established Products Division. He was appointed to his role in July 2013. Previously, he served as Divisional Vice President, EMEA East, and Division Vice President, Pharmaceuticals, Europe South.
Mr. Pavee joined Abbott in 1992, after serving as European Sales Manager, France for Aguettant, S.A.
Mister Pavée received his undergraduate degree from the Ecole Supérieure des Sciences Commerciales d’Angers, France; and his MBA from HEC Paris MBA, Jouy-en-Josas, France.
Daniel Salvadori is Abbott’s Senior Vice President, Established Pharmaceuticals, Latin America. He assumed this role in September 2014.
Prior to joining Abbott, Daniel was Chief Executive Officer, LATAM for CFR Pharmaceuticals.
Under Daniel’s leadership, Abbott’s pharmaceutical business in Latin America continues to make a positive difference in the lives of millions of people. “We improve lives in Latin America every second,” he says. “Every second of every day, more than 60 people benefit from one of our products.”
Daniel earned his bachelor’s degree in economics from Hebrew University, Jerusalem, Israel; and a master’s degree in business administration from the Harvard Business School, Boston, Massachusetts.
Jared Watkin is Abbott’s Senior Vice President, Diabetes Care.
Prior to assuming this role in June 2o15, he served as Divisional Vice President, Technical Operations.
Jared joined our company in 1996, when Abbott acquired Medisense, Inc. Since then, he’s held a number of key positions in Abbott Diabetes Care, including Senior R&D Director and Divisional Vice President, Research and Development.
In what he describes as his "proudest Abbott moment," Jared led the team that developed our innovative Freestyle Libre Flash Glucose Monitoring System; and as he looks to the future, he's committed to "keeping Abbott Diabetes Care at the forefront of innovation, allowing us to provide better health, and a fuller life, to people with diabetes."
Jared earned his Bachelors of Science degree in Biochemistry from the University College of Wales, Aberystwyth, United Kingdom.
Brian Yoor is Senior Vice President Finance and Chief Financial Officer. He was appointed to his current position in June 2015. He previously served as Vice President, Investor Relations.
Brian joined Abbott in August 1997, and held various financial management positions of increasing responsibility, including Controller positions in the pharmaceutical, nutrition, and diagnostic businesses, before being asked to lead Abbott’s Investor Relations effort in January 2013.
Prior to joining Abbott, Brian was a certified public accountant with Arthur Andersen and held financial positions in the consumer industry with the Scotts Company and Newell Rubbermaid.
“In Abbott Finance, we are the stewards that enable financial reliability and growth for Abbott, “ Says Brian. “ A strong, growing company is better able to help people around the world live their healthiest lives.”
Brian serves on the board of the Clara Abbott Foundation. He is a member of NIRI, the National Investor Relations Institute.
He earned his bachelor’s degree in accounting at the University of Toledo in Ohio.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.